Target intelligence / Profile preview

Integrated stress response pathway (ISR)

Target
ISR
Molecular classification
Other (signaling pathway/biochemical pathway), Enzyme, Protein kinase
01

Overview

The Integrated Stress Response pathway is a fundamental, evolutionarily conserved signaling network that enables eukaryotic cells to sense and respond to a variety of stressors, including nutrient deprivation, viral infection, hypoxia, and protein misfolding. Its core event is the phosphorylation of eIF2α by one of four sensor kinases: PERK (ER stress), GCN2 (amino acid deprivation), PKR (viral infection/double-stranded RNA), and HRI (heme depletion or mitochondrial stress). Phosphorylated eIF2α leads to global inhibition of protein synthesis and selective translation of adaptive genes, notably ATF4. This program helps restore cellular homeostasis or, under prolonged or severe stress, triggers apoptosis. Individual components of the ISR, especially its sensor kinases and regulatory effectors, are clinically relevant as therapeutic targets in cancer, neurodegeneration, infection, and other diseases, whereas the pathway as a whole is not a single druggable target.

Other names
Integrated stress responseeIF2α phosphorylation pathwayeIF2 signalingISR pathway
02

Mechanism of action

Inhibition or activation of eIF2α kinases (PERK, GCN2, PKR, HRI) to modulate eIF2α phosphorylation Modulation of translation initiation and selective mRNA translation Induction or blockade of ATF4 and downstream cytoprotective, pro-apoptotic, or immune regulatory pathways

03

Biological functions

Cellular homeostasisProtein synthesis regulationStress adaptationSignal transductionCell survivalCell death (apoptosis)Proteostasis (protein homeostasis)
04

Disease associations

CancerNeurodegenerative diseaseInflammatory diseaseMetabolic diseaseViral infectionGenetic disorders with proteostasis disruption
05

Safety considerations

Dual roles in cell survival and death (context-dependent pro-survival or pro-apoptotic effects)Potential toxicity from widespread inhibition or activation (e.g., neurotoxicity, impaired adaptation to physiological stress)Resistance and adaptation in cancer therapy by upregulation of anti-apoptotic signals (MCL-1, cIAPs)
06

Interacting drugs

Halofuginone

9 more in the full profile.

07

Biomarkers

Phosphorylated eIF2α (p-eIF2α)ATF4 expressionUpregulation of target genes such as CHOP, GADD34Expression of cIAP1, cIAP2, and MCL-1

Beyond the preview

Go deeper on Integrated stress response pathway (ISR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integrated stress response pathway (ISR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call